Abstract:Crystal structure of MBILF-BTRY complex was successfully solved by molecular replacement method and its 3-dimensional molecular model was thereby derived. Mung boon trypsin inhibitor belongs to Bowman Birk inhibitor group; which is by far the most complicated among the ten fundamental groups of serine protease inhibitor, Neither the 3 dimensional structure of Bowman Birk inhibitor group nor the stereoscopic conformation of its complex with protease has ever been reported. The crystallographic data of MBILF-BTRY complex are found to be a = 62.99 angstrom b = 65.54 angstrom, c = 69.70 angstrom , alpha = beta = gamma = 90 degrees; space group P2(1)2(1)2(1) and Z=4. Its molecular weight is about 27500 dalton. On a Rigaku AFC-5 four circle diffractometer attached to a RU-300 rotating anode generator, 5142 independent reflections of up to 3 angstrom, resolution were collected, The model BTRY coordinates are those of the refined BTRY taken from Protein Data Bank, Relative orientation angles between the model BTRY and BTRY our crystal alpha =145 degrees, beta = 46 degrees and gamma = 75 degrees (expressed in terms of Crowther angles), were obtained by using Crowther's fast rotation function. with diffraction data of 4 angstrom resolution, Translation function of three pairs of molecules related by three screw axes 2, were calculated by applying Lattman's program. From the implications revealed by the predominant peaks on the three Harker sections, the relative translation. components between the model BTRY and that in our crystal were found to be Delta x = -10.1 angstrom, Delta y = 3.0 angstrom and Delta z = 13.3 angstrom. Group refinement had improved the above rotational and translational parameters and gave the following results, alpha =146 degrees, beta = 45.7 degrees and gamma = 74.4 degrees and Delta z = -13.08 angstrom. After the model BTRY molecule was oriented and located in the correct azimuth and position within the cell according to the refined parameters, the R-factor dropped to 0.390. An electron density map and a difference map both of 3 angstrom resolution were (calculated with coefficients of 2 vertical bar F-0 vertical bar - vertical bar F-e vertical bar and vertical bar F-9 vertical bar - vertical bar F-e vertical bar respectively and with Sim-weighted phases. Dense contour levels apparently attributable to the MBILF could be clearly seen near the active site of BTRY molecule. The molecular size of MBILF was approximately estimated at 15x 15x25 angstrom. It could Le unambiguously discerned that the electron density corresponding to the long side chain of Lys 20 of MAIL? emir rule extends deeply no the specific pocket and terminates near Asp 189 OD1 of BTRY. The polypeptide folding could be traced in the Fourier map with reference to the difference Fourier. And a preliminary stereoscopic model of MBILF has been already constructed. Different from the usual protease inhibitors of known 3-dimensional structure, the striking feature of the MBILF is that its polypeptide folding does not include any secondary structure, such as alpha-helix and well defined beta-pleated sheet structure. Three large distorted rings each composed of nine to ten amino acid residues are cross-linked by four disulphide bridges to form a wedge-shaped structure with the head part sharpened arround the residue Lys 20 of MBILF and flattened gradually backwards. This enables the MBILF molecule to approach easily the active site of the BTRY and to bind tightly with the latter. The conformation of the head part of MBILF is similar to that of Kazal inhibitor group. In comparison with the pancreatic trypsin inhibitor (PTI), Bowman-Birk inhibitor is somewhat more involved in forming hydrogen bonds. The refinement of the MBILF-BTRY structure at higher resolution is now in progress. The 3-dimensional structure of MBILF-BTRY complex reveals for the first time a stereoscopic pattern of Bowman-Birk type inhibitor which may well be conducive to the structure-function correlation studies.

Crystal Structure of the Complex Formed Between Bovine Β-Trypsin and MCTI-A, a Trypsin Inhibitor of Squash Family, at 1.8-Å Resolution

THE REFINED 1.6 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PORCINE BETA-TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY

Crystal Structure of a Cyclic Form of Bovine Pancreatic Trypsin Inhibitor.

X-Ray study on an artificial mung bean inhibitor complex with bovine β-trypsin in neat cyclohexane

CRYSTAL STRUCTURE ANALYSIS' AND MOLECULAR MODEL OF MUNG BEAN TRYPSIN INHIBITOR LYS ACTIVE FRAGMANT-BOVINE TRYPSIN (MBILF-BTRY) COMPLEX AT 3.0 angstrom RESOLUTION

Trypsin inhibition by macrocyclic and open-chain variants of the squash inhibitor MCoTI-II

X-ray Studies on Two Forms of Bovine Β-Trypsin Crystals in Neat Cyclohexane

Crystal Structure of β-Trypsin Complex with Amylamine in Cyclohexane

Crystal structure of the Michaelis complex of trypsin with N‐α‐benzoyl‐l‐arginine ethyl ester

The X-ray Crystal Structure Analysis of the Complex Formed Between Momordica Charantia L. Trypsin Inhibitor-1 and Porcine Trypsin

Crystal structure of beta-trypsin complex with amylamine in cyclohexane

Refined 1.8Å Resolution Crystal Structure of the Porcine Ε-Trypsin

Conformational changes of rBTI from buckwheat upon binding to trypsin: implications for the role of the P(8)' residue in the potato inhibitor I family.

Crystal Structure of Human Cystatin D, a Cysteine Peptidase Inhibitor with Restricted Inhibition Profile

Structure of Carboxypeptidase T from Thermoactinomyces Vulgaris in Complex with L-Phenyl Lactate

The structural basis of Trp192 and the C-terminal region in trichosanthin for activity and conformational stability.

The Ternary Structure of the Double-headed Arrowhead Protease Inhibitor API-A Complexed with Two Trypsins Reveals a Novel Reactive Site Conformation

Refined 1.8 A resolution crystal structure of the porcine epsilon-trypsin.

Refined 1.8-Angstrom Resolution Crystal-Structure Of The Porcine Epsilon-Trypsin

Crystal Structures of the Glu(18), Gln(18), Asp(18) and Asn(18) Variants of Turkey Ovomucoid Inhibitor Third Domain Complexed with Streptomyces Griseus Proteinase B at Various Phs.